CHEMOTHERAPY CERTIFICATION EXAMS SCRIPT
2025/2026 ANSWERS AND QUESTIONS GRADED A+
✔✔Cetuximab - ✔✔Acneform rash
✔✔Ipilimumab - ✔✔Immune mediated S/E
TX= STEROIDS
✔✔Pembrolizumab - ✔✔Immune mediated toxicities:
Manage immune mediated toxicities with high dose steroids
✔✔Rituximab - ✔✔for CD20+ lymphocytes
✔✔Trastuzumab - ✔✔Cardiac issues
Administered in HER 2+ disease
✔✔Erlotinib - ✔✔Rash (75% of pts)
✔✔Arsenic trioxide - ✔✔Serum electrolyte Mg
✔✔Thalidomide - ✔✔Teratogenicity
BLACK BOX WARNING: DO NOT GIVE TO WOMEN WITH RISK OF PREGNANCY
✔✔Hydroxyurea - ✔✔Radiosensitizer
✔✔Bicalutamide - ✔✔MOA-> blocks effects of androgens on prostate
✔✔LHRH Agonists and LHRH Antagonists - ✔✔ACUTE: Increases in hormones- hot
flashes, osteoporosis, high cholesterol, wt gain, depression
CHRONIC: effects from decreased hormone production- loss of muscle mass, cognitive
changes, anemia, sexual dysfunction, gynecomastia
✔✔Aromatase inhibitors- Anastrazole - ✔✔Osteoporosis
Give to post-menopausal women only
✔✔SERMS (Tamoxifen) - ✔✔Menopausal symptoms
Risk of endometrial cancer
Thrombosis risk
✔✔Amifoxtine - ✔✔Tissue protectant: nephrotoxicity & neurotoxicity w/ cisplatin
Radiation protection: prevents acute or late xerostomia when radiation field includes
parotids
2025/2026 ANSWERS AND QUESTIONS GRADED A+
✔✔Cetuximab - ✔✔Acneform rash
✔✔Ipilimumab - ✔✔Immune mediated S/E
TX= STEROIDS
✔✔Pembrolizumab - ✔✔Immune mediated toxicities:
Manage immune mediated toxicities with high dose steroids
✔✔Rituximab - ✔✔for CD20+ lymphocytes
✔✔Trastuzumab - ✔✔Cardiac issues
Administered in HER 2+ disease
✔✔Erlotinib - ✔✔Rash (75% of pts)
✔✔Arsenic trioxide - ✔✔Serum electrolyte Mg
✔✔Thalidomide - ✔✔Teratogenicity
BLACK BOX WARNING: DO NOT GIVE TO WOMEN WITH RISK OF PREGNANCY
✔✔Hydroxyurea - ✔✔Radiosensitizer
✔✔Bicalutamide - ✔✔MOA-> blocks effects of androgens on prostate
✔✔LHRH Agonists and LHRH Antagonists - ✔✔ACUTE: Increases in hormones- hot
flashes, osteoporosis, high cholesterol, wt gain, depression
CHRONIC: effects from decreased hormone production- loss of muscle mass, cognitive
changes, anemia, sexual dysfunction, gynecomastia
✔✔Aromatase inhibitors- Anastrazole - ✔✔Osteoporosis
Give to post-menopausal women only
✔✔SERMS (Tamoxifen) - ✔✔Menopausal symptoms
Risk of endometrial cancer
Thrombosis risk
✔✔Amifoxtine - ✔✔Tissue protectant: nephrotoxicity & neurotoxicity w/ cisplatin
Radiation protection: prevents acute or late xerostomia when radiation field includes
parotids